12.31
+0.34(+2.84%)
Currency In USD
| Previous Close | 11.97 |
| Open | 12.06 |
| Day High | 12.51 |
| Day Low | 12.06 |
| 52-Week High | 15.69 |
| 52-Week Low | 8.64 |
| Volume | 1.06M |
| Average Volume | 1.66M |
| Market Cap | 1.98B |
| PE | 246.2 |
| EPS | 0.05 |
| Moving Average 50 Days | 11.52 |
| Moving Average 200 Days | 11.69 |
| Change | 0.34 |
If you invested $1000 in Certara, Inc. (CERT) since IPO date, it would be worth $323.27 as of October 21, 2025 at a share price of $12.31. Whereas If you bought $1000 worth of Certara, Inc. (CERT) shares 3 years ago, it would be worth $1,086.5 as of October 21, 2025 at a share price of $12.31.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Certara Scientists are Among the Topmost Cited Biopharma Researchers
GlobeNewswire Inc.
12 hours ago
Certara celebrates its 200 published papers and 11 scientists on Stanford/Elsevier top 2% cited researchers list in 2025RADNOR, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development,
Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025
GlobeNewswire Inc.
Oct 10, 2025 12:00 PM GMT
RADNOR, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2025 after the market close on Thursday, November 6th, 20
Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster
GlobeNewswire Inc.
Sep 04, 2025 12:00 PM GMT
Solution delivers a 50% reduction in time spent drafting mapping specifications, according to internal measurementsRADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the a